Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. AnaptysBio Inc shares valued at $842,060 were purchased by EcoR1 Capital, LLC on Dec 30 ’24. At $12.92 per share, EcoR1 Capital, LLC acquired 65,184 shares. The insider’s holdings grew to 7,860,180 shares worth approximately $167.19 million following the completion of this transaction.
Also, EcoR1 Capital, LLC purchased 13,268 shares, netting a total of over 171,513 in proceeds. Following the buying of shares at $12.93 each, the insider now holds 7,873,448 shares.
Before that, EcoR1 Capital, LLC had added 6,646 shares to its account. In a trade valued at $86,070, the Director bought AnaptysBio Inc shares for $12.95 each. Upon closing the transaction, the insider’s holdings increased to 6,646 shares, worth approximately $167.61 million.
As published in a research note from H.C. Wainwright on June 04, 2025, AnaptysBio Inc [ANAB] has been rated up from a Neutral to a Buy and the price target has been revised to $38. Analysts at Wolfe Research started covering the stock with ‘”an Outperform”‘ outlook in a report released in early February. As of December 11, 2024, H.C. Wainwright has decreased its “Buy” rating to a “Neutral” for ANAB. Earlier on December 02, 2024, BTIG Research downgraded its rating. Their new recommendation was “a Neutral” for ANAB stock which previously was a “a Buy”.
Analyzing ANAB Stock Performance
During the last five days, there has been a surge of approximately 1.77%. Over the course of the year, AnaptysBio Inc shares have jumped approximately 60.65%. Shares of the company reached a 52-week high of $24.68 on 06/04/25 and a 52-week low of $12.21 on 02/11/25.
Support And Resistance Levels for AnaptysBio Inc (ANAB)
According to the 24-hour chart, there is a support level at 19.45, which, if violated, would cause prices to drop to 17.64. In the upper region, resistance lies at 23.88. The next price resistance is at 26.50. RSI (Relative Strength Index) is 52.36 on the 14-day chart, showing neutral technical sentiment.
Which companies own the most shares of AnaptysBio Inc (ANAB)?
On July 22, 2024, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $55.
